"Researchers at the University at Buffalo found that the RNA-binding protein TTP helps control 'inflammaging'. Genetically modified elderly mice with stable TTP levels showed improved strength, bone health, and immune profiles. The study suggests that manipulating TTP could eventually lead to interventions for human aging-related frailty. Human applications remain far in the future as drug screening efforts are in early stages."